CV Technologies
This article was originally published in The Tan Sheet
Executive Summary
Initiating Phase II trial of "immune stimulant" ginseng extract CVT-E002 with $500,000 grant from Canadian government. The product is marketed in the U.S. as Cold-FX by Amrion, a division of Whole Foods, under its BioDynamax and Physio-Logics dietary supplement lines ("The Tan Sheet" March 9, p. 7). CV Technologies distributes Cold-FX in Canada. The company is planning to pursue Rx status for CVT-E002 in both countries